相关实验视频

Updated: Jan 9, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

索卡:基于网络的计算框架,以克服MCF7细胞的获得性他莫西芬抗性

Mijin Kwon, Young Min Woo, Woochang Hwang

IEEE transactions on computational biology and bioinformatics

|December 5, 2025

概括

这项研究介绍了SOCAR,这是一个计算工具,用于预测克服抗癌药物耐药性的敏感药物. 索卡成功地发现了对抗他莫西芬乳腺癌的有效敏感剂,通过体外实验验证实了这一点.

科学领域:

计算生物学是一种计算生物学.
药理学药理学是指药理学的学科.
在瘤学瘤学.

背景情况:

耐药性是癌症化疗中的一个重要障碍.
与敏感剂结合治疗提供了一种有希望的方法来克服抗性.
对敏感剂的实验查是资源密集型的,需要计算解决方案.

研究的目的:

开发一个计算框架,SOCAR,用于预测敏感药物.
为了确定抗药性癌症的新型敏感剂.
阐明阻力逆转的机制.

主要方法:

集成的转录组形状与分子相互作用网络.
开发了一个基于网络的计算框架 (SOCAR).
量化药物潜在的逆转抗药机制.

主要成果:

SOCAR准确地预测了对坦莫西芬耐药乳腺癌的敏感剂 (AUROC = 0.90).
实验室内验证证实,顶级候选者的细胞活力显著降低.
蛋白质活性分析表明,通过联合治疗恢复了抵抗模块蛋白质.

结论:

索卡为发现新型敏感药物提供了一个高效的系统级框架.
开发的方法有助于理解和逆转癌症耐药机制.
这种方法可以加速对抗性癌症的组合疗法的识别.

更多相关视频

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay

Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay

Published on: April 3, 2009

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...